Donations
World Diabetes Foundation
In financial terms, Novo Nordisk's biggest single commitment is its annual donation to the World Diabetes Foundation. At the company's Annual General Meeting in 2002, the shareholders made an agreement obliging the company over a 10-year period to make an annual donation of 0.25% of the net insulin sales for the preceding financial year (not to exceed 65 million Danish kroner or 15% of taxable income). In March 2008, the shareholders of Novo Nordisk A/S approved of an additional endowment of a maximum of DKK 575 million over another ten year-period, bringing the two endowments from Novo Nordisk A/S up to a total maximum of DKK 1.2 billion in the period 2001 - 2017.
In 2008 the donations amounted to DKK 69.3 million.
The Novo Nordisk Haemophilia Foundation (NNHF)
The Novo Nordisk Haemophilia Foundation was set up in 2005 as part of the company’s commitment to social responsibility within haemophilia care. It is also a response to the significant need to improve haemophilia treatment in developing countries. NNHF supports sustainable local and regional projects as well as the advancement of relations between healthcare professionals, patient associations and authorities within the haemophilia community. NNHF operates on an annual donation of approximately DKK 10 million from Novo Nordisk.
Global and local impact
Besides making financial donations, Novo Nordisk contributes to socio-economic welfare by securing and creating employment, by developing the competences of its employees, and by making products and offering services that provide better health for people with diabetes and others whose healthcare needs are served by the company. The economic stakeholder model illustrates Novo Nordisk, its economic stakeholders, and the interactions that drive economic growth in society.
Education and health infrastructure
As a response to the diabetes pandemic, Novo Nordisk is driving a number of activities to raise awareness of diabetes and improve healthcare systems. Corporate investments are modest in financial terms when compared with the impact and the local benefits. 2008 activities in this area include the following:
- The DAWN programme (Diabetes Attitudes, Wishes and Needs)


